Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Lebret

Showing results (111-120 of 149) with videos related to

Pageof 15
Sort By:
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 1, 1997
[Isolated Burch type indirect colposuspension of the bladder neck in the treatment of stress urinary incontinence in women. Long-term results]T Lebret, L Yonneau, E Chartier-Kastler, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 30, 2009
[The impact of partial nephrectomy on morbidity and on long-term oncological outcomes]Y Rouach, M-O Timsit, T Lebret, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 1, 2011
[Healing and targeted therapies: Management in perioperative period?]G Pignot, T Lebret, D Chekulaev, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 4, 2014
[CCAFU Recommendations 2013: Diagnosis, treatment, follow up of urological cancers]M Soulié, P Coloby, J Irani, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 7, 2010
[Recommendations of good clinical practice: diagnosis, treatment and monitoring of urological cancers in men and women.]M Soulié, P Coloby, J Irani, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 7, 2010
[Projected incidence and mortality from urologic cancer in France in 2010.]X Rébillard, P Grosclaude, T Lebret, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 14, 2015
[Not Available]A Mejean, T Lebret, V Verkarre, et al.
World Journal of Urology|May 20, 2005
Piboserod (SB 207266), a selective 5-HT4 receptor antagonist, reduces serotonin potentiation of neurally-mediated contractile responses of human detrusor muscleB Darblade, D Behr-Roussel, D Gorny, et al.
European Urology|June 1, 2000
Prognostic value of MIB-1 antibody labeling index to predict response to Bacillus Calmette-Guérin therapy in a high-risk selected population of patients with stage T1 grade G3 bladder cancerT Lebret, V Becette, J M Hervé, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 5, 2012
[Are therapeutics decisions homogeneous in multidisciplinary onco-urology staff meeting? Comparison of therapeutic options taken in four departments from Paris]F Audenet, V Lejay, A Mejean, et al.
Pageof 15

Showing results (111-120 of 149) with videos related to

Sort By:
Pageof 15
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 1, 1997
[Isolated Burch type indirect colposuspension of the bladder neck in the treatment of stress urinary incontinence in women. Long-term results]T Lebret, L Yonneau, E Chartier-Kastler, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 30, 2009
[The impact of partial nephrectomy on morbidity and on long-term oncological outcomes]Y Rouach, M-O Timsit, T Lebret, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 1, 2011
[Healing and targeted therapies: Management in perioperative period?]G Pignot, T Lebret, D Chekulaev, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 4, 2014
[CCAFU Recommendations 2013: Diagnosis, treatment, follow up of urological cancers]M Soulié, P Coloby, J Irani, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 7, 2010
[Recommendations of good clinical practice: diagnosis, treatment and monitoring of urological cancers in men and women.]M Soulié, P Coloby, J Irani, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 7, 2010
[Projected incidence and mortality from urologic cancer in France in 2010.]X Rébillard, P Grosclaude, T Lebret, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 14, 2015
[Not Available]A Mejean, T Lebret, V Verkarre, et al.
World Journal of Urology|May 20, 2005
Piboserod (SB 207266), a selective 5-HT4 receptor antagonist, reduces serotonin potentiation of neurally-mediated contractile responses of human detrusor muscleB Darblade, D Behr-Roussel, D Gorny, et al.
European Urology|June 1, 2000
Prognostic value of MIB-1 antibody labeling index to predict response to Bacillus Calmette-Guérin therapy in a high-risk selected population of patients with stage T1 grade G3 bladder cancerT Lebret, V Becette, J M Hervé, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 5, 2012
[Are therapeutics decisions homogeneous in multidisciplinary onco-urology staff meeting? Comparison of therapeutic options taken in four departments from Paris]F Audenet, V Lejay, A Mejean, et al.
Pageof 15